Bacterial cellulose nanoparticles as a sustainable drug delivery platform for protein-based therapeutics
RSC Applied Polymers · 2024 · 2 (2) · 172-183
DOI: 10.1039/d3lp00184a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Applied Polymers, 2024. Verfasst von Gabrielle N. Balistreri und 6 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: University of Washington, National Science Foundation, Molecular Engineering and Sciences Institute, University of Washington.
Abstract (Originalsprache)
BCNPs prepared from a kombucha co-culture can serve as a sustainable delivery platform for protein-based drugs. The amorphous nanoparticles form a mesh-like fibrillar network that is thermally stable and can be produced at scale.
Förderung
- University of Washington
- National Science Foundation
- Molecular Engineering and Sciences Institute, University of Washington
- Clean Energy Institute
- U.S. Department of Energy
Zitieren
APA
Balistreri, G. N., Campbell, I. R., Li, X., Amorim, J., Zhang, S., Nance, E., & Roumeli, E. (2024). Bacterial cellulose nanoparticles as a sustainable drug delivery platform for protein-based therapeutics. RSC Applied Polymers, 2(2), 172-183. https://doi.org/10.1039/d3lp00184a
Vancouver
Balistreri GN, Campbell IR, Li X, Amorim J, Zhang S, Nance E, et al. Bacterial cellulose nanoparticles as a sustainable drug delivery platform for protein-based therapeutics. RSC Applied Polymers. 2024;2(2):172-183. doi:10.1039/d3lp00184a
BibTeX
@article{Balistreri2024,
author = {Balistreri, Gabrielle N. and Campbell, Ian R. and Li, Xinqi and Amorim, Julia and Zhang, Shuai and Nance, Elizabeth and Roumeli, Eleftheria},
title = {Bacterial cellulose nanoparticles as a sustainable drug delivery platform for protein-based therapeutics},
journal = {RSC Applied Polymers},
year = {2024},
volume = {2},
number = {2},
pages = {172--183},
doi = {10.1039/d3lp00184a}
}
EUVIMED